Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Elevance Health Q1 2024 Adj EPS $10.64 Beats $10.53 Estimate, Sales $42.273B Miss $42.626B Estimate

Author: Benzinga Newsdesk | April 18, 2024 06:02am
Elevance Health (NYSE:ELV) reported quarterly earnings of $10.64 per share which beat the analyst consensus estimate of $10.53 by 1.04 percent. This is a 12.47 percent increase over earnings of $9.46 per share from the same period last year. The company reported quarterly sales of $42.273 billion which missed the analyst consensus estimate of $42.626 billion by 0.83 percent. This is a 0.90 percent increase over sales of $41.898 billion the same period last year.

Posted In: ELV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist